Herbal Doctor Remedies Hair Back Lotion recall — FDA D-1130-2020
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Complete FDA and NHTSA recall records dated in 2020, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.